Sucampo/Takeda Chronic Constipation Agent Amitiza Indicated For All Adults

Sucampo and marketing partner Takeda's newly approved chronic idiopathic constipation treatment Amitiza is indicated for use in a broader patient population than Novartis' Zelnorm

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet